Remove 2019 Remove Patients Remove Prescription
article thumbnail

Insurance companies putting profits ahead of patients

World of DTC Marketing

Five of America’s largest health insurers reported more than $11bn in profits in the second quarter – a decline from the same period last year when the Covid-19 pandemic helped drive sky-high profits yet they are having more of a say on patients’ treatments even when HCPs disagree. Then there is prior authorization.

Insurance 225
article thumbnail

Biden proposes subsidizing drug middlemen for insulin

World of DTC Marketing

Under the bill proposed, Medicare beneficiaries and those insured through private plans would pay no more than $35 for a 30-day insulin prescription, or the lesser of $35 or 25% of the plan’s negotiated price for a 30-day prescription. This could cost taxpayers billions over the year. 2 by the PBM Accountability Project.

Insurance 240
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The fairytale of DTC TV ads

World of DTC Marketing

Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales. According to a 2019 study from Kantar , a whopping 70 percent of consumers say they see the same ads over and over again. ” Ninety-two percent of U.S. Nowhere is this clearer than in pharma DTC TV ads.

article thumbnail

Is DTC effective?

World of DTC Marketing

Among the 26% of respondents who talked to a health care provider about a specific prescription drug they saw advertised, 16% said they received a prescription for the advertised drug. Online research is used to evaluate new prescription drugs. But is this really true across all DTC? Is TV the best channel?

article thumbnail

 The US accounts for more than 40% of all health spending.

World of DTC Marketing

Hospitals, physicians, and clinical care made up more than half of the total healthcare spending in 2019. According to federal data, annual per-person spending growth for workplace health insurance has exceeded the spending growth among Medicare and Medicaid patients in nine of the past 13 years. Half of U.S.

Insurance 154
article thumbnail

New FDA head needs to examine the accelerated approval program

World of DTC Marketing

The FDA’s “accelerated approval” program expedites the evaluation process for new treatments so that patients can have access to them sooner. Between 2011 and 2018, cumulative spending on 44 FDA-approved oral targeted therapy drugs was $3.5

FDA 234
article thumbnail

Opioid Prescriptions for US Patients With Cancer, Non-Cancer Pain Falls, Study Results Show

Pharmacy Times

Analysis looks at those with arthritis, chronic pain, headaches, lower back pain, and neuropathic pain between 2012 and 2019.